What people are saying about this resource:

I appreciate the GFR guidance as they are slightly different for the SGLT2 meds and this is a helpful resource for that.   Also the check boxes for ASCVD high risk, CKD, and heart failure.
These were not meds that I was very comfortable prescribing at first. This dosing guide has been extremely helpful in knowing how/when to start and to titrate.  It is easy to use and read, while still providing the information that we need.
I really liked this resource.  It pulled a lot of information into one place, concise and organized, a very useful tool for clinicians.  This is something I plan to print out and keep as a reference.  This would also be a great reference for learners.

MCT2D Resource: Dosing Information for SGLT-2 Inhibitors and GLP-1 Receptor Agonists for Type 2 Diabetes

Updated: 08/22/24

Key dosing information for SGLT2-I and GLP1-RAs including dose escalation, pen and needle RX considerations, proven benefits for ASCVD, CKD, HFrEF, HFpEF, and DKD.

Tags: For Providers, Created By MCT2D, Point-of-care, Nephrology

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org